Quick search
Advanced search in
Research outcomes
Field to searchTerm
Add rule
Filters (5)
The following results are related to COVID-19. Are you interested to view more results? Visit OpenAIRE - Explore.
Download Results
667 research outcomes, page 1 of 67
  • publication . Article . 2021
    Open Access English
    Authors:
    Moncef Belhassen-García; Antonio Sánchez-Puente; Pedro-Ignacio Dorado-Díaz; Amparo López-Bernús; Jesús Sampedro-Gómez; Raúl Azibeiro-Melchor; Edgard Marcano-Millán; Beatriz Rodríguez-Alonso; María-Elisa Sánchez-Barrado; Ignacio Hernández-García; ...
    Persistent Identifiers
    Publisher: MDPI AG

    Background: The evidence for the efficacy of glucocorticoids combined with tocilizumab (TCZ) in COVID-19 comes from observational studies or subgroup analysis. Our aim was to compare outcomes between hospitalized COVID-19 patients who received high-dose corticosteroid p...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Erika Olivia Boyesen; Ida Maria Balsby; Marius Henriksen; Robin Christensen; Jens Henning Rasmussen; Finn Erland Nielsen; Hanne Nygaard; Lennart Jan Friis-Hansen; Susanne Dam Nielsen; Rebekka Faber Thudium; ...
    Persistent Identifiers
    Publisher: MDPI AG
    Country: Denmark

    C-reactive protein (CRP) has prognostic value in hospitalized patients with COVID-19; the importance of CRP in pre-hospitalized patients remains to be tested. Methods: Individuals with symptoms of COVID-19 had a SARS-CoV-2 PCR oropharyngeal swab test, and a measurement ...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Laura Angelici; Chiara Sorge; Mirko Di Martino; Giovanna Cappai; Massimo Stafoggia; Nera Agabiti; Enrico Girardi; Simone Lanini; Emanuele Nicastri; Marina Davoli; ...
    Persistent Identifiers
    Publisher: MDPI AG

    Evidence on social determinants of health on the risk of SARS-CoV-2 infection and adverse outcomes is still limited. Therefore, this work investigates educational disparities in the incidence of infection and mortality within 30 days of the onset of infection during 202...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Francesca Favieri; Giuseppe Forte; Francesca Agostini; Jasmine Giovannoli; Enrico Di Pace; Viviana Langher; Renata Tambelli; Mariella Pazzaglia; Anna Maria Giannini; Maria Casagrande;
    Persistent Identifiers
    Publisher: MDPI AG
    Country: Italy

    The pandemic period which has characterized the last two years has been associated with increasingly worsening psychological conditions, and previous studies have reported severe levels of anxiety, mood disorder, and psychopathological alteration in the general populati...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Juan García-Bernalt Diego; Pedro Fernández-Soto; Juan Luis Muñoz-Bellido; Begoña Febrer-Sendra; Beatriz Crego-Vicente; Cristina Carbonell; Amparo López-Bernús; Miguel Marcos; Moncef Belhassen-García; Antonio Muro;
    Persistent Identifiers
    Publisher: MDPI

    Detection of SARS-CoV-2 is routinely performed in naso/oropharyngeal swabs samples from patients via RT-qPCR. The RT-LAMP technology has also been used for viral RNA detection in respiratory specimens with both high sensitivity and specificity. Recently, we developed a ...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Alessandra Colombini; Michele Davide Maria Lombardo; Laura de Girolamo; Elena De Vecchi; Riccardo Giorgino; Giuseppe Maria Peretti; Giuseppe Banfi; Laura Mangiavini;
    Persistent Identifiers
    Publisher: Multidisciplinary Digital Publishing Institute
    Country: Italy

    Background: The coronavirus disease 2019 (COVID-19) pandemic outbreak has posed new problems in the context of patients suffering from other diseases. In particular, musculoskeletal sequelae related to the state of debilitation associated with COVID-19 are important to ...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Dana Crisan; Lucretia Avram; Cristiana Grapa; Alexandra Dragan; Dan Radulescu; Sorin Crisan; Alin Grosu; Valentin Militaru; Elena Buzdugan; Laurentiu Stoicescu; ...
    Persistent Identifiers
    Publisher: Multidisciplinary Digital Publishing Institute

    Liver involvement in Coronavirus Disease 2019 (COVID-19) has been widely documented. However, data regarding liver-related prognosis are scarce and heterogeneous. The current study aims to evaluate the role of abnormal liver tests and incidental elevations of non-invasi...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Lukas Buchwinkler; Claire Anne Solagna; Janosch Messner; Markus Pirklbauer; Michael Rudnicki; Gert Mayer; Julia Kerschbaum;
    Persistent Identifiers
    Publisher: MDPI AG

    Most trials on mRNA vaccines against SARS-CoV-2 did not include patients with chronic kidney disease (CKD), hemodialysis (HD) patients, or kidney transplant recipients (KTR). However, those patients have a higher risk for a severe course of COVID-19 disease and mortalit...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Yuichiro Takeshita; Jiro Terada; Yasutaka Hirasawa; Taku Kinoshita; Hiroshi Tajima; Ken Koshikawa; Toru Kinouchi; Yuri Isaka; Yu Shionoya; Atsushi Fujikawa; ...
    Persistent Identifiers
    Publisher: MDPI AG

    Although previous studies have revealed that elevated D-dimer in the early stage of coronavirus 2019 (COVID-19) indicates pulmonary intravascular coagulation, the state of coagulation/fibrinolysis disorder with normal D-dimer is unknown. The study aimed to investigate h...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Ryota Inokuchi; Toshiki Kuno; Jun Komiyama; Kazuaki Uda; Yoshihisa Miyamoto; Yuta Taniguchi; Toshikazu Abe; Miho Ishimaru; Motohiko Adomi; Nanako Tamiya; ...
    Persistent Identifiers
    Publisher: MDPI

    Nafamostat mesylate may be effective against coronavirus disease 2019 (COVID-19). However, it is not known whether its use is associated with reduced in-hospital mortality in clinical practice. We conducted a retrospective observational study to evaluate the effect of n...

    Add to ORCIDorcid
667 research outcomes, page 1 of 67